Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study

Chronic Fatigue Syndrome (CFS) is a multisystem illness, which may be associated with imbalances in gut microbiota. This study builds on recent evidence that sleep may be influenced by gut microbiota, by assessing whether changes to microbiota in a clinical population known to have both poor sleep a...

Full description

Bibliographic Details
Main Authors: Melinda L. Jackson, Henry Butt, Michelle Ball, Donald P. Lewis, Dorothy Bruck
Format: Article
Language:English
Published: Thieme Revinter Publicações Ltda. 2015-11-01
Series:Sleep Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1984006315000632
_version_ 1797368522566795264
author Melinda L. Jackson
Henry Butt
Michelle Ball
Donald P. Lewis
Dorothy Bruck
author_facet Melinda L. Jackson
Henry Butt
Michelle Ball
Donald P. Lewis
Dorothy Bruck
author_sort Melinda L. Jackson
collection DOAJ
description Chronic Fatigue Syndrome (CFS) is a multisystem illness, which may be associated with imbalances in gut microbiota. This study builds on recent evidence that sleep may be influenced by gut microbiota, by assessing whether changes to microbiota in a clinical population known to have both poor sleep and high rates of colonization with gram-positive faecal Streptococcus, can improve sleep. Twenty-one CFS participants completed a 22- day open label trial. Faecal microbiota analysis was performed at baseline and at the end of the trial. Participants were administered erythromycin 400 mg b.d. for 6 days. Actigraphy and questionnaires were used to monitor sleep, symptoms and mood. Changes in patients who showed a clinically significant change in faecal Streptococcus after treatment (responders; defined as post-therapy distribution<6%) were compared to participants who did not respond to treatment. In the seven responders, there was a significant increase in actigraphic total sleep time (p=0.028) from baseline to follow up, compared with non-responders. Improved vigour scores were associated with a lower Streptococcus count (ρ=−0.90, p=0.037). For both the responders and the whole group, poorer mood was associated with higher Lactobacillus. Short term antibiotic treatment appears to be insufficient to effect sustainable changes in the gut ecosystem in most CFS participants. Some improvement in objective sleep parameters and mood were found in participants with reduced levels of gram-positive gut microbiota after antibiotic treatment, which is encouraging. Further study of possible links between gut microorganisms and sleep and mood disturbances is warranted.
first_indexed 2024-03-08T17:32:44Z
format Article
id doaj.art-7151322c43764abeae8f322e93343970
institution Directory Open Access Journal
issn 1984-0063
language English
last_indexed 2024-03-08T17:32:44Z
publishDate 2015-11-01
publisher Thieme Revinter Publicações Ltda.
record_format Article
series Sleep Science
spelling doaj.art-7151322c43764abeae8f322e933439702024-01-02T13:50:57ZengThieme Revinter Publicações Ltda.Sleep Science1984-00632015-11-018312413310.1016/j.slsci.2015.10.001Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot studyMelinda L. Jackson0Henry Butt1Michelle Ball2Donald P. Lewis3Dorothy Bruck4College of Arts, Victoria University, Victoria, AustraliaBioscreen (Aust) Pty Ltd., Victoria, AustraliaCollege of Arts, Victoria University, Victoria, AustraliaCFS Discovery, Victoria, AustraliaCollege of Arts, Victoria University, Victoria, AustraliaChronic Fatigue Syndrome (CFS) is a multisystem illness, which may be associated with imbalances in gut microbiota. This study builds on recent evidence that sleep may be influenced by gut microbiota, by assessing whether changes to microbiota in a clinical population known to have both poor sleep and high rates of colonization with gram-positive faecal Streptococcus, can improve sleep. Twenty-one CFS participants completed a 22- day open label trial. Faecal microbiota analysis was performed at baseline and at the end of the trial. Participants were administered erythromycin 400 mg b.d. for 6 days. Actigraphy and questionnaires were used to monitor sleep, symptoms and mood. Changes in patients who showed a clinically significant change in faecal Streptococcus after treatment (responders; defined as post-therapy distribution<6%) were compared to participants who did not respond to treatment. In the seven responders, there was a significant increase in actigraphic total sleep time (p=0.028) from baseline to follow up, compared with non-responders. Improved vigour scores were associated with a lower Streptococcus count (ρ=−0.90, p=0.037). For both the responders and the whole group, poorer mood was associated with higher Lactobacillus. Short term antibiotic treatment appears to be insufficient to effect sustainable changes in the gut ecosystem in most CFS participants. Some improvement in objective sleep parameters and mood were found in participants with reduced levels of gram-positive gut microbiota after antibiotic treatment, which is encouraging. Further study of possible links between gut microorganisms and sleep and mood disturbances is warranted.http://www.sciencedirect.com/science/article/pii/S1984006315000632Chronic Fatigue SyndromeSleepActigraphyIntestinal dysbiosisMood
spellingShingle Melinda L. Jackson
Henry Butt
Michelle Ball
Donald P. Lewis
Dorothy Bruck
Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study
Sleep Science
Chronic Fatigue Syndrome
Sleep
Actigraphy
Intestinal dysbiosis
Mood
title Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study
title_full Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study
title_fullStr Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study
title_full_unstemmed Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study
title_short Sleep quality and the treatment of intestinal microbiota imbalance in Chronic Fatigue Syndrome: A pilot study
title_sort sleep quality and the treatment of intestinal microbiota imbalance in chronic fatigue syndrome a pilot study
topic Chronic Fatigue Syndrome
Sleep
Actigraphy
Intestinal dysbiosis
Mood
url http://www.sciencedirect.com/science/article/pii/S1984006315000632
work_keys_str_mv AT melindaljackson sleepqualityandthetreatmentofintestinalmicrobiotaimbalanceinchronicfatiguesyndromeapilotstudy
AT henrybutt sleepqualityandthetreatmentofintestinalmicrobiotaimbalanceinchronicfatiguesyndromeapilotstudy
AT michelleball sleepqualityandthetreatmentofintestinalmicrobiotaimbalanceinchronicfatiguesyndromeapilotstudy
AT donaldplewis sleepqualityandthetreatmentofintestinalmicrobiotaimbalanceinchronicfatiguesyndromeapilotstudy
AT dorothybruck sleepqualityandthetreatmentofintestinalmicrobiotaimbalanceinchronicfatiguesyndromeapilotstudy